Cargando…

A comprehensive review on promising anti-viral therapeutic candidates identified against main protease from SARS-CoV-2 through various computational methods

BACKGROUND: The COVID-19 pandemic caused by SARS-CoV-2 has shown an exponential trend of infected people across the planet. Crediting its virulent nature, it becomes imperative to identify potential therapeutic agents against the deadly virus. The 3-chymotrypsin-like protease (3CLpro) is a cysteine...

Descripción completa

Detalles Bibliográficos
Autores principales:	Singh, Ekampreet, Khan, Rameez Jabeer, Jha, Rajat Kumar, Amera, Gizachew Muluneh, Jain, Monika, Singh, Rashmi Prabha, Muthukumaran, Jayaraman, Singh, Amit Kumar
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2020
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7607901/ https://www.ncbi.nlm.nih.gov/pubmed/33141358 http://dx.doi.org/10.1186/s43141-020-00085-z

Ejemplares similares

Prioritization of Mur family drug targets against A. baumannii and identification of their homologous proteins through molecular phylogeny, primary sequence, and structural analysis
por: Amera, Gizachew Muluneh, et al.
Publicado: (2020)

A computational essential dynamics approach to investigate structural influences of ligand binding on Papain like protease from SARS-CoV-2
por: Singh, Ekampreet, et al.
Publicado: (2022)

Identification and prioritization of potential therapeutic molecules against LpxA from Acinetobacter baumannii – A computational study
por: Khan, Rameez Jabeer, et al.
Publicado: (2023)

Non-Steroidal Anti-Inflammatory Drug Effect on the Binding of Plasma Protein with Antibiotic Drug Ceftazidime: Spectroscopic and In Silico Investigation
por: Sajid Ali, Mohd, et al.
Publicado: (2023)

Analysis of SARS-CoV-2 mutations in the main viral protease (NSP5) and its implications on the vaccine designing strategies
por: Yashvardhini, Niti, et al.
Publicado: (2022)

Analysis of SARS-CoV-2 mutations in the main viral protease (NSP5) and its implications on the vaccine designing strategies
por: Yashvardhini, Niti, et al.
Publicado: (2022)

Budesonide: A promising candidate therapeutic for early COVID-19
por: Patel, Shailesh Kumar, et al.
Publicado: (2021)

Phytoconstituents from ten natural herbs as potent inhibitors of main protease enzyme of SARS-COV-2: In silico study
por: Kumar, Nitish, et al.
Publicado: (2021)

Screening and evaluation of approved drugs as inhibitors of main protease of SARS-CoV-2
por: Tripathi, Praveen Kumar, et al.
Publicado: (2020)

Hunting the main protease of SARS-CoV-2 by plitidepsin: Molecular docking and temperature-dependent molecular dynamics simulations
por: Vishvakarma, Vijay Kumar, et al.
Publicado: (2021)

Interactions between main protease of SARS-CoV-2 and testosterone or progesterone using computational approach
por: Vishvakarma, Vijay Kumar, et al.
Publicado: (2022)

Current Scenario and Future Prospects of Endophytic Microbes: Promising Candidates for Abiotic and Biotic Stress Management for Agricultural and Environmental Sustainability
por: Anand, Uttpal, et al.
Publicado: (2023)

Insect protease inhibitors; promising inhibitory compounds against SARS-CoV-2 main protease
por: Hemmati, Seyed Ali, et al.
Publicado: (2022)

Naturally occurring anthraquinones as potential inhibitors of SARS-CoV-2 main protease: an integrated computational study
por: Das, Sourav, et al.
Publicado: (2022)

Nano-Messengers of the Heart: Promising Theranostic Candidates for Cardiovascular Maladies
por: Yedavilli, Sneha, et al.
Publicado: (2022)

Exploitation of reverse vaccinology and immunoinformatics as promising platform for genome-wide screening of new effective vaccine candidates against Plasmodium falciparum
por: Pritam, Manisha, et al.
Publicado: (2019)

Dual binding mode of antithyroid drug methimazole to mammalian heme peroxidases – structural determination of the lactoperoxidase–methimazole complex at 1.97 Å resolution
por: Singh, Rashmi Prabha, et al.
Publicado: (2016)

Rapid structure-based identification of potential SARS-CoV-2 main protease inhibitors
por: Sobhia, M Elizabeth, et al.
Publicado: (2021)

Structural Basis of the Main Proteases of Coronavirus Bound to Drug Candidate PF-07321332
por: Li, Jian, et al.
Publicado: (2022)

Structural Basis of Main Proteases of Coronavirus Bound to Drug Candidate PF-07304814
por: Li, Jian, et al.
Publicado: (2022)

Evaluation of acridinedione analogs as potential SARS-CoV-2 main protease inhibitors and their comparison with repurposed anti-viral drugs
por: Bhardwaj, Vijay Kumar, et al.
Publicado: (2021)

Computer Aided Drug Design Approach to Screen Phytoconstituents of Adhatoda vasica as Potential Inhibitors of SARS-CoV-2 Main Protease Enzyme
por: Siva Kumar, Bathula, et al.
Publicado: (2022)

Molecular dynamics analysis of phytochemicals from Ageratina adenophora against COVID-19 main protease (M(pro)) and human angiotensin-converting enzyme 2 (ACE2)
por: Neupane, Netra Prasad, et al.
Publicado: (2021)

In silico prediction of potential inhibitors for the main protease of SARS-CoV-2 using molecular docking and dynamics simulation based drug-repurposing
por: Kumar, Yogesh, et al.
Publicado: (2020)

Microsecond MD Simulation and Multiple-Conformation Virtual Screening to Identify Potential Anti-COVID-19 Inhibitors Against SARS-CoV-2 Main Protease
por: Selvaraj, Chandrabose, et al.
Publicado: (2021)

A Potential Peptide From Soy Cheese Produced Using Lactobacillus delbrueckii WS4 for Effective Inhibition of SARS-CoV-2 Main Protease and S1 Glycoprotein
por: Chourasia, Rounak, et al.
Publicado: (2020)

Curcumin, a traditional spice component, can hold the promise against COVID-19?
por: Soni, Vivek Kumar, et al.
Publicado: (2020)

Current therapeutic modalities and chemopreventive role of natural products in liver cancer: Progress and promise
por: Singh, Amit Kumar, et al.
Publicado: (2023)

Benchmarking the ability of novel compounds to inhibit SARS-CoV-2 main protease using steered molecular dynamics simulations
por: Singh, Rahul, et al.
Publicado: (2022)

In silico studies on structural inhibition of SARS-CoV-2 main protease M(pro) by major secondary metabolites of Andrographis paniculata and Cinchona officinalis
por: Majumdar, Moumita, et al.
Publicado: (2022)

Computational screening for potential drug candidates against the SARS-CoV-2 main protease
por: Silva Andrade, Bruno, et al.
Publicado: (2020)

First structure–activity relationship analysis of SARS-CoV-2 virus main protease (Mpro) inhibitors: an endeavor on COVID-19 drug discovery
por: Amin, Sk. Abdul, et al.
Publicado: (2021)

Insilico generation of novel ligands for the inhibition of SARS-CoV-2 main protease (3CL(pro)) using deep learning
por: Prabhakaran, Prejwal, et al.
Publicado: (2023)

Protease targeted COVID-19 drug discovery and its challenges: Insight into viral main protease (Mpro) and papain-like protease (PLpro) inhibitors
por: Amin, Sk. Abdul, et al.
Publicado: (2021)

Validation of candidate gene-based EST-SSR markers for sugar yield in sugarcane
por: Divakar, S., et al.
Publicado: (2023)

Global gene expression profiling under nitrogen stress identifies key genes involved in nitrogen stress adaptation in maize (Zea mays L.)
por: Singh, Prabha, et al.
Publicado: (2022)

Cathelicidin-trypsin inhibitor loop conjugate represents a promising antibiotic candidate with protease stability
por: Yu, Haining, et al.
Publicado: (2017)

E-learning during the COVID-19 Pandemic in Various Healthcare Institutes of India
por: Kumar, Surender, et al.
Publicado: (2022)

Inhibition Potencies of Phytochemicals Derived from Sesame Against SARS-CoV-2 Main Protease: A Molecular Docking and Simulation Study
por: Kumar, Anuj, et al.
Publicado: (2021)

Identification of key interactions between SARS-CoV-2 main protease and inhibitor drug candidates
por: Yoshino, Ryunosuke, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_rv10ve393ltg734tl6rms6k25q